Senate Council Meeting: “When there is a temporary reduction in Pathology Laboratory capacity, how can pathology demand be managed or reduced with the least possible risk of clinical harm?”
On the 26th November 2020 the Clinical Senate deliberated the questions:
“When there is a temporary reduction in Pathology Laboratory capacity, how can pathology demand be managed or reduced with the least possible risk of clinical harm?
Presentations
Bruce Daniel Pathology Laboratory Capacity in the South West – Clinical senate 26.11.20
Bruce, Pathology Service Manager & South 1 incident director
SW Clinical Senate – Sadie Thomas
Dr Sadie Thomas, Principal Clinical Biochemist, Gloucestershire Royal Hospital
Citizens’ Assembly Contribution
Nick Pennell, Chair of SW Citizens’ Assembly
Agenda
20.11.26 Agenda-Senate Council_
Recommendations
FINAL Clinical Senate Recommendations – Pathology Prioritisation – Nov 26th 2020